GH Research Newsroom

Stifel Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $18

Futu NewsNov 21 21:31 · Ratings

Does GH Research (GHRS) Have the Potential to Rally 225.18% as Wall Street Analysts Expect?

Yahoo FinanceNov 20 22:55

GH Research Q3 2024 Results and Clinical Updates

TipRanksNov 20 11:57

H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40

Futu NewsNov 20 01:32 · Ratings

Promising Advancements in GH Research's Clinical Trials Boost Buy Rating

TipRanksNov 20 01:05 · Ratings

GH Research Is Maintained at Buy by Canaccord Genuity

Dow JonesNov 18 22:31 · Ratings

GH Research Analyst Ratings

BenzingaNov 18 22:20 · Ratings

Express News | GH Research PLC : Canaccord Genuity Cuts Target Price to $28 From $31

BreakingsNov 18 16:30

Express News | U.S.-Listed Shares of ATAI Life Sciences up 9.1%

BreakingsNov 15 22:34

Express News | GH Research Shares up 4.1%

BreakingsNov 15 22:33

Express News | Compass Pathways Shares up 11.9%

BreakingsNov 15 22:33

Express News | Shares of Psychedelic Drug Developers Rise After Rfk Jr Picked for Top US Health Agency Role

BreakingsNov 15 22:33

RFK and the 'MAHA Trade': Vaccine Makers Down, Psychedelic Shares up

Seeking AlphaNov 15 19:02

TD Cowen Maintains GH Research(GHRS.US) With Buy Rating

Futu NewsNov 15 13:33 · Ratings

JMP Securities Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39

Futu NewsNov 15 05:32 · Ratings

GH Research's Promising Clinical Progress and Financial Strength Reaffirm Buy Rating With $39 Price Target

TipRanksNov 15 04:55 · Ratings

GH Research Q3 2024 GAAP EPS $(0.23) Beats $(0.25) Estimate

BenzingaNov 14 20:55

GH Research | 6-K: Report of foreign private issuer (related to financial reporting)

SECNov 14 20:16 · Announcements

Express News | GH Research PLC: Qtrly Net Loss per Share $0.23

BreakingsNov 14 20:09

Press Release: GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates

Dow JonesNov 14 20:00